 | Up a level |
Sanyal, Arun J; Anstee, Quentin M; Trauner, Michael; Lawitz, Eric J; Abdelmalek, Manal F; Ding, Dora; Han, Ling; Jia, Catherine; Huss, Ryan S; Chung, Chuhan; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Romero-Gomez, Manuel; Muir, Andrew J; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary; Harrison, Stephen A; Younossi, Zobair M and Myers, Robert P (2022). Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis. Hepatology, 75(5), pp. 1235-1246. Wiley 10.1002/hep.32204
Loomba, Rohit; Huang, Daniel Q.; Sanyal, Arun J; Anstee, Quentin Mark; Trauner, Michael; Lawitz, Eric J; Ding, Dora; Ma, Lily; Jia, Catherine; Billin, Andrew; Huss, Ryan S; Chung, Chuhan; Goodman, Zachary; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Romero-Gómez, Manuel; Abdelmalek, Manal F; Muir, Andrew; Afdhal, Nezam; Bosch, Jaime; ... (2022). Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut, 72(3), pp. 581-589. BMJ Publishing Group 10.1136/gutjnl-2022-327777
Harrison, Stephen A; Abdelmalek, Manal F; Caldwell, Stephen; Shiffman, Mitchell L; Diehl, Anna Mae; Ghalib, Reem; Lawitz, Eric J; Rockey, Don C; Schall, Raul Aguilar; Jia, Catherine; McColgan, Bryan J; McHutchison, John G; Subramanian, G Mani; Myers, Robert P; Younossi, Zobair; Ratziu, Vlad; Muir, Andrew J; Afdhal, Nezam H; Goodman, Zachary; Bosch, Jaime; ... (2018). Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology, 155(4), pp. 1140-1153. Elsevier 10.1053/j.gastro.2018.07.006
